Multi-epitope antigen, immunogenic composition comprising said antigen, pneumococcal diagnostic kit, and uses of said antigen

WO2024259508A1PCT designated stage expired Publication Date: 2024-12-26INSTITUTO BUTANTAN
-1 Cites -1 Cited by

Patent Information

Application Number
PCT/BR2024/050260
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-06-22
Filing Date
2024-06-18
Publication Date
2024-12-26

Smart Images

  • Figure BR2024050260_26122024_PF_FP_ABST
    Figure BR2024050260_26122024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a multi-epitope antigen comprising 20 epitope blocks of 20 to 36 amino acids from proteins selected from the group consisting of NanA, PcsB, PhtD, Ply, PncO, StkP, PspA-F1 and PspA-F2. In addition, the present invention relates to an immunogenic composition comprising said antigen and a pharmaceutically acceptable vehicle and / or adjuvant. In addition, a pneumococcal diagnostic kit comprising said antigen or a biologically active fragment thereof bound to a detectable fraction; an antibody generated by said antigen; and instructions for use is also disclosed. In addition, the present invention relates to the use of said antigen to be used in the preparation of a vaccine to prevent diseases caused by pneumococcus bacteria; and for the production of monoclonal and polyclonal antibodies. Lastly, the present invention relates to an in vitro method for diagnosing pneumococcus which comprises applying the said antigen or a biologically active fragment of it bound to a detectable fraction, in contact with samples of body fluids selected from among blood, mucus expelled from the lower airways and urine.
Need to check novelty before this filing date? Find Prior Art